These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12663474)

  • 41. A novel zwitterionic inhibitor of aldose reductase interferes with polyol pathway in ex vivo and in vivo models of diabetic complications.
    Karasova MJ; Prnova MS; Stefek M
    Pharmazie; 2014 Oct; 69(10):747-51. PubMed ID: 25985564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased lenticular aldose reductase activity and high incidence of congenital cataract in the offspring of diabetic rats.
    Simán CM; Naeser P; Eriksson UJ
    Acta Ophthalmol (Copenh); 1993 Oct; 71(5):629-36. PubMed ID: 8109209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of dietary taurine supplementation on GSH and NAD(P)-redox status, lipid peroxidation, and energy metabolism in diabetic precataractous lens.
    Obrosova IG; Stevens MJ
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):680-8. PubMed ID: 10067971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatocyte growth factor induces proliferation of lens epithelial cells through activation of ERK1/2 and JNK/SAPK.
    Choi J; Park SY; Joo CK
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2696-704. PubMed ID: 15277494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitory effects of Ganoderma applanatum on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
    Jung SH; Lee YS; Shim SH; Lee S; Shin KH; Kim JS; Kim YS; Kang SS
    Phytother Res; 2005 Jun; 19(6):477-80. PubMed ID: 16114079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intrinsic inhibition of aldose reductase.
    Kador PF; Sun G; Rait VK; Rodriguez L; Ma Y; Sugiyama K
    J Ocul Pharmacol Ther; 2001 Aug; 17(4):373-81. PubMed ID: 11572468
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract.
    Suryanarayana P; Kumar PA; Saraswat M; Petrash JM; Reddy GB
    Mol Vis; 2004 Mar; 10():148-54. PubMed ID: 15031705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alterations in lens protein tyrosine phosphorylation and phosphatidylinositol 3-kinase signaling during selenite cataract formation.
    Chandrasekher G; Sailaja D
    Curr Eye Res; 2004 Feb; 28(2):135-44. PubMed ID: 14972719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altering the course of cataracts in diabetic rats.
    Fukushi S; Merola LO; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1980 Mar; 19(3):313-5. PubMed ID: 6766909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The protein binding of phenytoin, propranolol, diazepam, and AL01576 (an aldose reductase inhibitor) in human and rat diabetic serum.
    McNamara PJ; Blouin RA; Brazzell RK
    Pharm Res; 1988 May; 5(5):261-5. PubMed ID: 3149736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N; Tsui J; Johnson M
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does oxidative stress play any role in diabetic cataract formation? ----Re-evaluation using a thioltransferase gene knockout mouse model.
    Zhang J; Yan H; Lou MF
    Exp Eye Res; 2017 Aug; 161():36-42. PubMed ID: 28579033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E
    Diabetes; 1985 Jan; 34(1):15-21. PubMed ID: 3917257
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The role of lens epithelium in cataract formation in diabetic rats].
    Fan W; Yan M; Hu Y; Li G
    Hua Xi Yi Ke Da Xue Xue Bao; 1998 Jun; 29(2):185-8. PubMed ID: 10684012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beneficial influence of fungal metabolite nigerloxin on eye lens abnormalities in experimental diabetes.
    Suresha BS; Sattur AP; Srinivasan K
    Can J Physiol Pharmacol; 2012 Apr; 90(4):387-94. PubMed ID: 22423974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contributions of polyol pathway to oxidative stress in diabetic cataract.
    Lee AY; Chung SS
    FASEB J; 1999 Jan; 13(1):23-30. PubMed ID: 9872926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens.
    Gonzalez AM; Sochor M; Hothersall JS; McLean P
    Diabetes; 1986 Nov; 35(11):1200-5. PubMed ID: 3093302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of diabetic-cataract by vitamin K1 involves modulation of hyperglycemia-induced alterations to lens calcium homeostasis.
    Sai Varsha MK; Raman T; Manikandan R
    Exp Eye Res; 2014 Nov; 128():73-82. PubMed ID: 25257692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel high resolution in vivo digital imaging system for the evaluation of experimental cataract in diabetic rats.
    Kametaka S; Kasahara T; Ueo M; Takenaka M; Saito M; Sakamoto K; Nakahara T; Ishii K
    J Pharmacol Sci; 2008 Jan; 106(1):144-51. PubMed ID: 18187926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of insulin on aldose reductase activity in the lens of rats with streptozotocin-induced diabetes].
    Nishigami T
    Nippon Ganka Gakkai Zasshi; 1990 Feb; 94(2):128-34. PubMed ID: 2114733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.